Literature DB >> 15045195

[Pain treatment in geriatric patients].

H D Basler1, N Griessinger, U Hankemeier, D Märkert, T Nikolaus, W Sohn.   

Abstract

A primary goal of pain treatment in geriatric patients is the maintenance of physical and mental functions. This is a precondition for activity and participation. In patients with chronic pain, multidisciplinary treatment, without excluding invasive procedures, is the most effective approach. The medication ladder, initially suggested by the WHO for cancer pain, provides a guideline for pharmacological treatment. Due to age-dependent alterations in the kinetics and dynamics of pharmaceuticals, the titration of the medication follows the rule "start low-go slow". The same principle holds true for the maintenance or augmentation of physical activity in order to escape from the activity-deconditioning cycle. Training should be based on learning theories, include pain management strategies, and incorporate psychological approaches to facilitate the active participation of the patient in the treatment program. In hospitals and nursing homes, nurses play an important role in defining the need for pain treatment and in supervising the patient in the treatment process. Despite these endeavours, a significant number of patients remain whose pain cannot be controlled sufficiently. Euthanasia on demand for a patient with untreatable pain is not admitted in Germany.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045195     DOI: 10.1007/s00120-004-0541-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  Physicians' experiences with the Oregon Death with Dignity Act.

Authors:  L Ganzini; H D Nelson; T A Schmidt; D F Kraemer; M A Delorit; M A Lee
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

2.  Comparative safety evaluation of non-narcotic analgesics.

Authors:  S E Andrade; C Martinez; A M Walker
Journal:  J Clin Epidemiol       Date:  1998-12       Impact factor: 6.437

3.  COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

Authors:  Wayne A Ray; C Michael Stein; James R Daugherty; Kathi Hall; Patrick G Arbogast; Marie R Griffin
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

Review 4.  The management of persistent pain in older persons.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2002-06       Impact factor: 5.562

5.  Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.

Authors:  A Whelton; J G Fort; J A Puma; D Normandin; A E Bello; K M Verburg
Journal:  Am J Ther       Date:  2001 Mar-Apr       Impact factor: 2.688

6.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

Review 7.  Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.

Authors:  Johan W S Vlaeyen; Steven J Linton
Journal:  Pain       Date:  2000-04       Impact factor: 6.961

Review 8.  Multidisciplinary rehabilitation for chronic low back pain: systematic review.

Authors:  J Guzmán; R Esmail; K Karjalainen; A Malmivaara; E Irvin; C Bombardier
Journal:  BMJ       Date:  2001-06-23

Review 9.  Pharmacological treatments for persistent non-malignant pain in older persons.

Authors:  Thorsten Nikolaus; Andrej Zeyfang
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.